Excella GmbH & Co. KG
Excella GmbH & Co. KG lists 22 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 46014-0130 | Alectinib Hydrochloride Capsule | Alectinib Hydrochloride 150 mg/1 | Rx |
| 46014-7300 | azacitidine Tablet, Film Coated | Azacitidine 300 mg/1 | Rx |
| 46014-7200 | azacitidine Tablet, Film Coated | Azacitidine 200 mg/1 | Rx |
| 46014-6202 | busulfan Tablet, Film Coated | Busulfan 2 mg/1 | Rx |
| 46014-4751 | capecitabine Tablet, Film Coated | Capecitabine 500 mg/1 | Rx |
| 46014-6102 | chlorambucil Tablet, Film Coated | Chlorambucil 2 mg/1 | Rx |
| 46014-6010 | Emtricitabine Capsule | Emtricitabine 200 mg/1 | Rx |
| 46014-5010 | macitentan Tablet, Film Coated | Macitentan 10 mg/1 | Rx |
| 46014-2400 | neratinib Tablet | Neratinib Maleate Anhydrous 40 mg/1 | Rx |
| 46014-9076 | paroxetine Capsule | Paroxetine Mesylate 7.5 mg/1 | Rx |
| 46014-6280 | Selexipag Kit | Rx | |
| 46014-0621 | Selexipag Capsule | Selexipag .2 mg/1 | Rx |
| 46014-0608 | Selexipag Capsule | Selexipag .8 mg/1 | Rx |
| 46014-0602 | Selexipag Capsule | Selexipag .2 mg/1 | Rx |
| 46014-6302 | thioguanine Tablet | Thioguanine 40 mg/1 | Rx |
| 46014-8012 | Tryvio Capsule | Aprocitentan 12.5 mg/1 | Rx |
| 46014-6100 | Uptravi Capsule | Selexipag 1 mg/1 | Rx |
| 46014-6060 | Uptravi Capsule | Selexipag .6 mg/1 | Rx |
| 46014-6120 | Uptravi Capsule | Selexipag 1.2 mg/1 | Rx |
| 46014-6140 | Uptravi Capsule | Selexipag 1.4 mg/1 | Rx |
| 46014-6160 | Uptravi Capsule | Selexipag 1.6 mg/1 | Rx |
| 46014-6040 | Uptravi Capsule | Selexipag .4 mg/1 | Rx |